Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 106

Immune-Onc books $33m series B

Immune-Onc, an immuno-oncology therapy developer exploiting University of Texas research, has received more than $33m from investors including Stanford-StartX fund.

Sep 21, 2018

Blippar ships in $37m

Qualcomm Ventures co-led the series E round, which increased the AR and computer vision technology developer's overall funding to $137m.

Sep 21, 2018

Zumper jumps to $46m series C

The apartment rental marketplace has now raised $90m altogether, having secured $46m in an Axel Springer-backed round.

Sep 21, 2018

Ro satisfies craving with $88m

The Forbes-backed end-to-end healthcare product supplier has raised $88m in series A funding and added a smoking cessation service.

Sep 21, 2018

Jumia workshops $250m IPO

The Rocket Internet-backed e-commerce platform is considering an initial public offering in the US early next year at a valuation of $1bn.

Sep 21, 2018

Yi Jiupi toasts $200m series D

The online wine retailer has completed a round that was co-led by Tencent and Meituan Dianping at a reported $1.1bn valuation.

Sep 21, 2018

Uber explores 10-figure Deliveroo acquisition

NGP Capital-backed food delivery service Deliveroo was valued at $2bn as of November but a successful bid would need to be a sizeable upgrade.

Sep 21, 2018

Clippings clasps series B funding

The home design products marketplace has secured $15.4m in a round led by Advance Venture Partners, which will also get a board seat.

Sep 20, 2018

Oxbotica puts $18.5m in the tank

Autonomous vehicle software spinout Oxbotica has secured IP Group, Parkwalk Advisors and Axa XL as investors in its first publicly-disclosed funding round.

Sep 20, 2018

Twaice replenishes with $1.4m seed round

TUM-founded Twaice Technologies has won backing from UVC Partners to deliver battery management software targeting electric vehicles.

Sep 20, 2018
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here